Vanguardia, Khinn Luiz Roi C.
HRN: 23-83-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2025
CEFUROXIME 750MG (VIAL)
02/26/2025
03/05/2025
IV
375mg
Q8
Burn
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamSkin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes